Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: A one-year prospective study

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Alkharfy, Khalid M ^a,c   Al Daghri, Nasser M ^b,c   Sabico, Shaun B ^b,c   Al Othman, Abdulaziz ^d   Moharram, Osama ^e   Alokail, Majed S ^b,c   Al Saleh, Yousef ^c,f   Kumar, Sudhesh ^g   Chrousos, George P ^c,h  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^f KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^g UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Anti diabetes therapies; Diabetes mellitus; Vitamin D; Vitamin D supplementation

Indexed keywords

25 HYDROXYVITAMIN D; CHOLESTEROL; COLECALCIFEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; METFORMIN; ORAL ANTIDIABETIC AGENT; ROSIGLITAZONE; SULFONYLUREA; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 25-HYDROXYVITAMIN D; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; SULFONYLUREA DERIVATIVE; VITAMIN D;

ADULT; ANTHROPOMETRY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DIET; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTERVENTION STUDY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; SUN EXPOSURE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; DIET SUPPLEMENTATION; DIET THERAPY; DRUG COMBINATION; DRUG EFFECTS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; SAUDI ARABIA; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLECALCIFEROL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; MALE; METFORMIN; MIDDLE AGED; PROSPECTIVE STUDIES; SAUDI ARABIA; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES; TREATMENT OUTCOME; VITAMIN D; YOUNG ADULT;

EID: 84881057303     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-113     Document Type: Article

References (24)

1. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J, OPF Committee of Scientific Advisors (CSA) Nutrition Working Group Global vitamin D status and determinants of hipovitaminosis D. Osteoporos Int 2009, 20:1807-1820. 10.1007/s00198-009-0954-6, 19543765, OPF Committee of Scientific Advisors (CSA) Nutrition Working Group.
2. Prentice A. Vitamin D, deficiency: a global perspective. Nutr Rev 2008, 66:S153-S164.
3. Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, Montonen J, Reunanen A. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diab Care 2007, 30:2569-2570.
4. Maalouf G, Gannage-Yared MH, Ezzedine J, Larijani B, Badawi S, Rached A, Zakroui L, Masri B, Azar E, Saba E, Nammari R, Adib G, ABou Samra H, Alrawi Z, Salman S, El Muntasser K, Tarseen R, El Kharousi W, Al-Lamki M, Alothman AN, Almarzooki N, El Dessouki M, Sulaimani R, Saleh J, Suhaili AR, Khan A, Delmas P, Seeman E. Middle East and North Africa consensus on osteoporosis. J Muskuloskelet Neuronal Interact 2007, 7:131-143.
5. Al-Daghri NM, Alkharfy KM, Al-Saleh Y, Al-Attas OS, Alokail MS, Al-Othman A, Moharram O, El-Kholie E, Sabico S, Kumar S, Chrousos GP. Modest reversal of metabolic syndrome manifestations with vitamin D correction: A 12-month prospective study. Metabolism 2012, 61:661-666. 10.1016/j.metabol.2011.09.017, 22075268.
6. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, El-Kholie E, Yousef M, Al-Othman A, Al-Saleh Y, Sabico S, Kumar S, Chrousos GP. Increased Vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle-Eastern residents. Clin Endo 2012, 76:346-350.
7. Al-Daghri NM, Alkharfy KM, El-Kholie E, Yousef M, Al-Othman A, Al-Saleh Y, Sabico S, Kumar S, Chrousos GP. Vitamin D supplementation as an adjuvant therapy for Saudi patients with DMT2: an 18-month interventional study. Cardiovasc Diabetol 2012, 11:85. 10.1186/1475-2840-11-85, 3461474, 22809461.
8. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Sabico SLS, Chrousos GP. Diabetes mellitus Type 2 and other chronic non-communicable diseases in the Central Region, Saudi Arabia (Riyadh Cohort 2): A Decade of an Epidemic. BMC Med 2011, 9:76. 10.1186/1741-7015-9-76, 3141541, 21689399.
9. Guasch A, Bullo M, Rabassa A, Bonada A, Del Castillo D, Sabench F, Salas-Salvado J. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc Diabetol 2012, 11:149. 10.1186/1475-2840-11-149, 3541071, 23228198.
10. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Al-Yousef MA, Nadhrah HM, Sabico SB, Chrousos GP. Severe hypovitaminosis D is widespread in Saudi adults and is more common in non-diabetics than diabetics. Saudi Med J 2010, 31:775-780.
11. Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, Shargorodsky M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 2013, S0261-5614(13)00047-2.
12. Yiu YF, Yiu KH, Siu CW, Chan YH, Li SW, Wong LY, Lee SW, Tam S, Wong EW, Lau CP, Cheung BM, Tse HF. Randomized controlled trial of vitamin D supplement on endotelial function in patients with type 2 diabetes. Atherosclerosis 2013, 227:140-146. 10.1016/j.atherosclerosis.2012.12.013, 23298824.
13. Pilz S, Kienreich K, Rutters F, De Jongh R, Van Ballegooijen AJ, Grubler M, Tomaschitz A, Dekker JM. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep 2013, 13:261-270. 10.1007/s11892-012-0358-4, 23264189.
14. Avandia (rosiglitazone maléate tablets) prescribing information 2008, http://us.gsk.com/products/asset/us_avandia.pdf Glaxo SmithKline: Research Triangle Park, NC.
15. Ogata T, Miyauchi T, Sakai S, Irukiyama-Tomobe Y, Goto K, Yamaguchi I. Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts. Clin Sci (Lond) 2002, 103:284S-288S.
16. Rahimi-Ardabili H, Pourghassem Gargari B, Farzadi L. Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency. J Endocrinol Invest 2013, 36:28-32.
17. Ponda MP, Dowd K, Finkielstein D, Holt PR, Breslow JL. The short-term effects of vitamin D repletion on cholesterol: a randomized, placebo-controlled trial. Arteroscler Thromb Vasc Biol 2012, 32:2510-2515.
18. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, Simpson WG, Fraser WD, Reid DM, Macdonald HM. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012, 97:3557-3568. 10.1210/jc.2012-2126, 22865902.
19. Kazlauskaite R, Powell LH, Mandapakala C, Cursio JF, Avery EF, Calvin J. Vitamin D is associated with atheroprotective high density lipoprotein profile in postmenopausal women. J Clin Lipidol 2010, 4:113-119. 10.1016/j.jacl.2010.01.006, 3390416, 21122638.
20. Auwerx J, Bouillon R, Kestellot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-1, and high density lipoprotein cholesterol. Arterioscler Thromb 1992, 12:671-674. 10.1161/01.ATV.12.6.671, 1350464.
21. Calvert GD, Graham JJ, Mannik T, Wise PH, Yeates RA. Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus. Lancet 1978, 2:66-68.
22. Romano G, Patti L, Innelli F, Di Marino L, Annuzzi G, Iavicoli M, Coronel GA, Riccardi G, Rivellese AA. Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?. Diab 1997, 46:1601-1606.
23. Rivellese AA, Patti L, Romano G, Innelli F, Di Marino L, Annuzzi G, Iavicoli M, Coronel GA, Riccardi G. Effect of insulin and sulfonylrea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients. J Clin Endocrinol Metab 2000, 85:4188-4192. 10.1210/jc.85.11.4188, 11095452.
24. Kos E, Liszek MJ, Emanuele MA, Durzo-Arvizu R, Camacho P. Effect of Metformin therapy on vitamin D and vitamin B12 levels in patients with type 2 diabetes mellitus. Endocr Pract 2012, 18:179-184. 10.4158/EP11009.OR, 21940283.